Sleep and Depression: What We Know and What to Learn?

References

1. 1. Patel V. et al. The Lancet Commission on global mental health and sustainable development // The Lancet. – 2018. – Vol. 392. – №10157. – P. 1553–1598.
2. 2. Wainberg M.L. et al. Challenges and opportunities in global mental health: a research-to-practice perspective // Current psychiatry reports. – 2017. – Vol. 19. – №5. – P. 28.
3. 3. World Health Organization et al. Depression and other common mental disorders: global health estimates. – World Health Organization, 2017. – № WHO/MSD/MER/2017.2.
4. 4. Horwitz A.V. Creating mental illness. – University of Chicago Press, 2020.
5. 5. Jeon S.W., Amidfar M., Kim Y.K. Bio-psycho-social risk factors for depression // Major Depressive Disorder: Risk Factors, Characteristics and Treatment Options. New York: Nova Science Publisher. – 2017. – P. 71–90.
6. 6. Salvat-Pujol N. et al. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: the role of remission status // Psychoneuroendocrinology. – 2017. – Vol. 76. – P. 38–48.
7. 7. Ketchesin K.D., Becker-Krail D., McClung C.A. Mood-related central and peripheral clocks // European Journal of Neuroscience. – 2020. – Vol. 51. – №1. – P. 326–345.
8. 8. Fang H. et al. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment // Journal of cellular and molecular medicine. – 2019. – Vol. 23. – №4. – P. 2324–2332.
9. 9. Caroleo M. et al. The role of hormonal, metabolic and inflammatory biomarkers on sleep and appetite in drug free patients with major depression: A systematic review // Journal of Affective Disorders. – 2019. – Vol. 250. – P. 249–259.
10. 10. Blake M.J., Trinder J.A., Allen N.B. Mechanisms underlying the association between insomnia, anxiety, and depression in adolescence: implications for behavioral sleep interventions // Clinical psychology review. – 2018. – Vol. 63. – P. 25–40.
11. 11. Shariq A.S. et al. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review // Progress in Neuro-Psychopharmacology and Biological Psychiatry. – 2019. – Vol. 92. – P. 1–7.
12. 12. Harvey J.R. M., Plante A.E., Meredith A.L. Ion Channels Controlling Circadian Rhythms in Suprachiasmatic Nucleus Excitability // Physiological Reviews. – 2020.
13. 13. Patke A., Young M.W., Axelrod S. Molecular mechanisms and physiological importance of circadian rhythms // Nature Reviews Molecular Cell Biology. – 2019. –P. 1–18.
14. 14. Luca G., Van Den Broecke S. Circadian rhythm sleep disorders: clinical picture, diagnosis and treatment // Revue medicale suisse. – 2020. – Vol. 16. – №698. – P. 1237–1242.
15. 15. Gupta R. et al. Clinical practice guidelines for sleep disorders // Indian journal of psychiatry. – 2017. – Vol. 59. – №. Suppl 1. – P. S116.
16. 16. Pandi-Perumal S. R. et al. Clarifying the role of sleep in depression: A narrative review // Psychiatry Research. – 2020. – P. 113239.
17. 17. Talbot L. et al. The role of sleep in mental illness in veterans and active service members // Military and Veteran Mental Health. – Springer, New York, NY, 2018. – P. 421–438.
18. 18. Robillard R. et al. Circadian rhythms and psychiatric profiles in young adults with unipolar depressive disorders // Translational psychiatry. – 2018. – Vol. 8. – №1. – P. 1–8.
19. 19. Charrier A. et al. Clock genes and altered sleep-wake rhythms: their role in the development of psychiatric disorders // International journal of molecular sciences. – 2017. – Vol. 18. – №5. – P. 938.
20. 20. Walker W H. et al. Circadian rhythm disruption and mental health // Translational Psychiatry. – 2020. – Vol. 10. – №1. – P. 1–13.
21. 21. Buoli M. et al. The role of clock genes in the etiology of Major Depressive Disorder: Special Section on «Translational and Neuroscience Studies in Affective Disorders». Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in... // Journal of Affective Disorders. – 2018. – Vol. 234. – P. 351–357.
22. 22. Liberman A. R. et al. Circadian clock model supports molecular link between PER3 and human anxiety // Scientific reports. – 2017. – Vol. 7. – №1. – P. 1–10.
23. 23. Satyanarayanan S.K. et al. Circadian rhythm and melatonin in the treatment of depression // Current Pharmaceutical Design. – 2018. – Vol. 24. – №22. – P. 2549–2555.
24. 24. Antypa N. et al. Chronotype associations with depression and anxiety disorders in a large cohort study // Depression and anxiety. – 2016. – Vol. 33. – №1. – P. 75–83.
25. 25. Sato F. et al. Functional analysis of the basic helix-loop-helix transcription factor DEC1 in circadian regulation: Interaction with BMAL1 // European Journal of Biochemistry. – 2004. – Vol. 271. – №22. – P. 4409–4419.
26. 26. Giguère V. Orphan nuclear receptors: from gene to function //Endocrine reviews. – 1999. – Vol. 20. – №5. – P. 689–725.
27. 27. Lowrey P.L., Takahashi J.S. Genetics of the mammalian circadian system: Photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation // Annual review of genetics. – 2000. – Vol. 34. – №1. – P. 533–562.
28. 28. Takahashi J. S. et al. The genetics of mammalian circadian order and disorder: implications for physiology and disease // Nature reviews genetics. – 2008. – Vol. 9. – №10. – P. 764–775.
29. 29. Kowalska E. et al. The circadian clock starts ticking at a developmentally early stage // Journal of biological rhythms. – 2010. – Vol. 25. – №6. – P. 442–449.
30. 30. Partonen T. Clock gene variants in mood and anxiety disorders // Journal of Neural Transmission. – 2012. – Vol. 119. – №10. – P. 1133–1145.
31. 31. Partonen T. Circadian clock genes and mood disorders // Melatonin, Neuroprotective Agents and Antidepressant Therapy. – Springer, New Delhi, 2016. – P. 319–334.
32. 32. Garbazza C., Benedetti F. Genetic factors affecting seasonality, mood, and the circadian clock // Frontiers in endocrinology. – 2018. – Vol. 9. – P. 481.
33. 33. Kripke D. F. et al. Circadian polymorphisms associated with affective disorders // Journal of circadian rhythms. – 2009. – Vol. 7. – №1. – P. 2.
34. 34. Utge S.J. et al. Systematic analysis of circadian genes in a population-based sample reveals association of TIMELESS with depression and sleep disturbance // PloS one. – 2010. – Vol. 5. – №2. – P. e9259.
35. 35. Lavebratt C. et al. PER2 variantion is associated with depression vulnerability // American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. – 2010. – Vol. 153. – №2. – P. 570–581.
36. 36. Soria V. et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder // Neuropsychopharmacology. – 2010. – Vol. 35. – №6. – P. 1279–1289.
37. 37. Kovanen L. et al. CRY2 genetic variants associate with dysthymia // PLoS One. – 2013. – Vol. 8. – №8. – P. e71450.
38. 38. Hua P. et al. Cry1 and Tef gene polymorphisms are associated with major depressive disorder in the Chinese population // Journal of affective disorders. – 2014. – Vol. 157. – P. 100–103.
39. 39. Byrne E.M. et al. Testing the role of circadian genes in conferring risk for psychiatric disorders // American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. – 2014. – Vol. 165. – №3. – P. 254–260.
40. 40. Shi S.Q. et al. Molecular analyses of circadian gene variants reveal sex-dependent links between depression and clocks // Translational psychiatry. – 2016. – Vol. 6. – №3. – P. e748–e748.
41. 41. Katzenberg D. et al. A CLOCK polymorphism associated with human diurnal preference // Sleep. – 1998. – Vol. 21. – №6. – P. 569–576.
42. 42. Desan P.H. et al. Genetic polymorphism at the CLOCK gene locus and major depression // American journal of medical genetics. – 2000. – Vol. 96. – №3. – P. 418–421.
43. 43. Bailer U. et al. No association of clock gene T3111C polymorphism and affective disorders // European Neuropsychopharmacology. – 2005. – Vol. 15. – №1. – P. 51–55.
44. 44. Kishi T. et al. Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population // European archives of psychiatry and clinical neuroscience. – 2009. – Vol. 259. – №5. – P. 293.
45. 45. Calati R. et al. T3111C clock single nucleotide polymorphism and mood disorders: a meta-analysis // Chronobiology international. – 2010. – Vol. 27. – №4. – P. 706–721.
46. 46. Serretti A. et al. 3111T/C clock gene polymorphism is not associated with sleep disturbances in untreated depressed patients // Chronobiology international. – 2010. – Vol. 27. – №2. – P. 265–277.
47. 47. Kishi T. et al. The CLOCK gene and mood disorders: a case-control study and meta-analysis // Chronobiology international. – 2011. – Vol. 28. – №9. – P. 825–833.
48. 48. Pirovano A. et al. Two new rare variants in the circadian «clock» gene may influence sleep pattern // Genetics in Medicine. – 2005. – Vol. 7. – №6. – P. 455–457.
49. 49. Kishi T. et al. Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population // Neuroscience Research. – 2008. – Vol. 62. – №4. – P. 211–215.
50. 50. Li S.X. et al. Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment // Psychoneuroendocrinology. – 2013. – Vol. 38. – №11. – P. 2789–2799.
51. 51. Li J.Z. et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder // Proceedings of the National Academy of Sciences. – 2013. – Vol. 110. – №24. – P. 9950–9955.
52. 52. Landgraf D., McCarthy M.J., Welsh D.K. The role of the circadian clock in animal models of mood disorders // Behavioral neuroscience. – 2014. – Vol. 128. – №3. – P. 344.
53. 53. Bunney B.G. et al. Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder // Molecular psychiatry. – 2015. – Vol. 20. – №1. – P. 48–55.
54. 54. Jiang W.G. et al. Chronic unpredictable stress induces a reversible change of PER2 rhythm in the suprachiasmatic nucleus // Brain research. – 2011. – Vol. 1399. – P. 25–32.
55. 55. Jiang W.G. et al. Hippocampal CLOCK protein participates in the persistence of depressive-like behavior induced by chronic unpredictable stress //Psychopharmacology. – 2013. – Vol. 227. – №1. – P. 79–92.
56. 56. Kinoshita C., Miyazaki K., Ishida N. Chronic stress affects PERIOD2 expression through glycogen synthase kinase-3β phosphorylation in the central clock // Neuroreport. – 2012. – Vol. 23. – №2. – P. 98–102.
57. 57. Christiansen S.L. et al. Altered expression pattern of clock genes in a rat model of depression // International Journal of Neuropsychopharmacology. – 2016. –Vol. 19. – №11.
58. 58. Takahashi K. et al. Chronic mild stress alters circadian expressions of molecular clock genes in the liver // American Journal of Physiology-Endocrinology and Metabolism. – 2013. – Vol. 304. – №3. – P. E301–E309.
59. 59. Wells A.M. et al. Effects of chronic social defeat stress on sleep and circadian rhythms are mitigated by kappa-opioid receptor antagonism // Journal of neuroscience. – 2017. – Vol. 37. – №32. – P. 7656–7668.
60. 60. Gest S. et al. Chronotherapeutic treatments for depression in youth // European child & adolescent psychiatry. – 2016. – Vol. 25. – №2. – P. 151–161.
61. 61. Cunningham J.E.A., Stamp J.A., Shapiro C.M. Sleep and major depressive disorder: A review of non-pharmacological chronotherapeutic treatments for unipolar depression // Sleep medicine. – 2019. – Vol. 61. – P. 6–18.
62. 62. Cunningham J.E.A. Investigating Chronotherapeutic Interventions for the Treatment of Depression. – 2018.
63. 63. Dallaspezia S. et al. Chronotype influences response to antidepressant chronotherapeutics in bipolar patients // Chronobiology International. – 2018. – Vol. 35. – №9. – P. 1319–1325.
64. 64. Kirschbaum-Lesch I., Holtmann M., Legenbauer T. Chronotherapy for Adolescent Major Depression // Neurotechnology and Brain Stimulation in Pediatric Psychiatric and Neurodevelopmental Disorders. – Academic Press, 2019. – P. 313–334.
65. 65. Satyanarayanan S.K. et al. Melatonergic agonist regulates circadian clock genes and peripheral inflammatory and neuroplasticity markers in patients with depression and anxiety // Brain, behavior, and immunity. – 2020. – Vol. 85. – P. 142–151.
66. 66. Dallaspezia S. et al. Sleep homeostatic pressure and PER3 VNTR gene polymorphism influence antidepressant response to sleep deprivation in bipolar depression // Journal of affective disorders. – 2016. – Vol. 192. – P. 64–69.
67. 67. Dmitrzak-Weglarz M., Reszka E. Pathophysiology of depression: Molecular regulation of melatonin homeostasis-current status // Neuropsychobiology. – 2017. – Vol. 76. – P. 117–129.
68. 68. D'Agostino A. et al. Efficacy of Triple Chronotherapy in Unipolar and Bipolar Depression: a systematic review of the available evidence // Journal of Affective Disorders. – 2020.
69. 69. Humpston C. et al. Chronotherapy for the rapid treatment of depression: A meta-analysis // Journal of affective disorders. – 2020. – Vol. 261. – P. 91–102.
70. 70. Mindlis I., Boffetta P. Mood disorders in first-and second-generation immigrants: systematic review and meta-analysis // The British Journal of Psychiatry. – 2017. – Vol. 210. – №3. – P. 182–189.
71. 71. da Costa Lane Valiengo L., Stella F., Forlenza O. V. Mood disorders in the elderly: prevalence, functional impact, and management challenges // Neuropsychiatric disease and treatment. – 2016.
72. 72. Mittal R. et al. Neurotransmitters: The critical modulators regulating gut-brain axis // Journal of cellular physiology. – 2017. – Vol. 232. – №9. – P. 2359–2372.
73. 73. Boakye P. A. et al. A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption // The Clinical Journal of Pain. – 2016. – Vol. 32. – №4. – P. 327–336.
74. 74. Liu B. et al. From serotonin to neuroplasticity: evolvement of theories for major depressive disorder // Frontiers in cellular neuroscience. – 2017. – Vol. 11. – P. 305.
75. 75. Kanady J.C. et al. The association between insomnia-related sleep disruptions and cognitive dysfunction during the inter-episode phase of bipolar disorder // Journal of psychiatric research. – 2017. – Vol. 88. – P. 80–88.
76. 76. Palagini L. et al. Insomnia symptoms predict emotional dysregulation, impulsivity and suicidality in depressive bipolar II patients with mixed features //Comprehensive psychiatry. – 2019. – Vol. 89. – P. 46–51.
77. 77. Asarnow L. D., Manber R. Cognitive behavioral therapy for insomnia in depression // Sleep medicine clinics. – 2019. – Vol. 14. – №2. – P. 177–184.
78. 78. Hallgren M. et al. Prospective relationships of mentally passive sedentary behaviors with depression: mediation by sleep problems //Journal of Affective Disorders. – 2020. – Vol. 265. – P. 538–544.
79. 79. Stickley A. et al. Sleep problems and depression among 237023 community-dwelling adults in 46 low-and middle-income countries // Scientific reports. – 2019. – Vol. 9. – №1. – P. 1–10.
80. 80. van de Laar M. et al. Correlates of general quality of life are different in patients with primary insomnia as compared to patients with insomnia and psychiatric comorbidity // Psychology, health & medicine. – 2017. – Vol. 22. – №2. – P. 172–183.
81. 81. Yoshiike T. et al. Mutual relationship between somatic anxiety and insomnia in maintaining residual symptoms of depression // Journal of Behavioral and Cognitive Therapy. – 2020.
82. 82. Langvik E. et al. Gender differences in factors associated with symptoms of depression among high school students: an examination of the direct and indirect effects of insomnia symptoms and physical activity // Health Psychology and Behavioral Medicine. – 2019. – Vol. 7. – №1. – P. 179–192.
83. 83. Dang-Vu T.T. et al. Neuroimaging in Normal and Abnormal Sleep // Sleep Disorders Medicine. – Springer, New York, NY, 2017. – P. 353–390.
84. 84. Maquet P., Fanielle J. Neuroimaging in normal sleep and sleep disorders //Oxford Textbook of Sleep Disorders. – Oxford, 2017. – P. 97.
85. 85. Nishida M. et al. Sleep complaints are associated with reduced left prefrontal activation during a verbal fluency task in patients with major depression: a multi-channel near-infrared spectroscopy study // Journal of affective disorders. – 2017. – Vol. 207. – P. 102–109.
86. 86. Freeman D. et al. Sleep disturbance and psychiatric disorders // The Lancet Psychiatry. – 2020. – Vol. 7. – №7. – P. 628–637.
87. 87. Franzen P.L., Buysse D.J. Sleep in psychiatric disorders // Sleep disorders medicine. – Springer, New York, NY, 2017. – P. 977–996.
88. 88. Dallaspezia S., Benedetti F. Sleep in other psychiatric disorders // Oxford Textbook of Sleep Disorders. – 2017. – P. 451.
89. 89. Dubrovsky B. et al. 0736 Self-reported Sleep in OSA Patients: Roles Of Polysomnographic Measures And Depressive Symptoms // Sleep. – 2020. – Vol. 43. – №Supplement_1. – P. A280–A280.
90. 90. Habukawa M. et al. Differences in rapid eye movement (REM) sleep abnormalities between posttraumatic stress disorder (PTSD) and major depressive disorder patients: REM interruption correlated with nightmare complaints in PTSD // Sleep medicine. – 2018. – Vol. 43. – P. 34–39.
91. 91. Chan M. S. et al. Sleep in schizophrenia: a systematic review and meta-analysis of polysomnographic findings in case-control studies // Sleep medicine reviews. – 2017. – Vol. 32. – P. 69–84.
92. 92. Abdul Rahman I., Yaqoob U., Bhatti T. A. Sleep Disorders Caused by Depression // Clin Depress. – 2018. – Vol. 4. – №131. – P. 2572–0791.
93. 93. Steiger A., Pawlowski M. Depression and sleep // International journal of molecular sciences. – 2019. – Vol. 20. – №3. – P. 607.
94. 94. Kang S.G. et al. Sleep and sleep disorders in depression //Understanding Depression. – Springer, Singapore, 2018. – P. 113–121.
95. 95. Prendes-Alvarez S., Nemeroff C. B. Personalized medicine: Prediction of disease vulnerability in mood disorders // Neuroscience Letters. – 2018. – Vol. 669. – P. 10–13.
96. 96. Zaki N.F. W. et al. Chronobiological theories of mood disorder //European archives of psychiatry and clinical neuroscience. – 2018. – Vol. 268. – №2. – P. 107–118.
97. 97. Extein I. et al. Antidepressants: predicting response/maximizing efficacy // Advances in Psychopharmacology: Improving Treatment Response. – 2018. – P. 30.
98. 98. Marek G.J. Translational Approaches for Antidepressant Drug Development // Handbook of Behavioral Neuroscience. – Elsevier, 2019. – Vol. 29. – P. 93–101.
99. 99. Perlman K. et al. A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder // Journal of affective disorders. – 2019. – Vol. 243. – P. 503–515.
100. 100. Gonzalez R., Gonzalez S. D., McCarthy M. J. Using Chronobiological Phenotypes to Address Heterogeneity in Bipolar Disorder // Molecular Neuropsychiatry. – 2019. – Vol. 5. – №1. – P. 72–84
101. 101. Angerer P. et al. Night work and the risk of depression: a systematic review // Deutsches Ärzteblatt International. – 2017. – Т. 114. – №24. – С. 404.
102. 102. Iasevoli F. et al. Chronobiology of Mood Disorders // Melatonin, Neuroprotective Agents and Antidepressant Therapy. – Springer, New Delhi, 2016. – P. 273–295.
103. 103. Baglioni C. et al. Sleep and mental disorders: A meta– analysis of polysomnographic research // Psychological bulletin. – 2016. – Vol. 142. – №9. – P. 969.
104. 104. Haberland L. et al. Changes in sleep architecture in German Armed Forces personnel with posttraumatic stress disorder compared with depressed and healthy control subjects // PloS one. – 2019. – Vol. 14. – №4. – P. e0215355.
105. 105. Léger D. et al. Slow– wave sleep: From the cell to the clinic //Sleep medicine reviews. – 2018. – Т. 41. – P. 113–132.
106. 106. Elovainio M. et al. Is moderate depression associated with sleep stage architecture in adolescence? Testing the stage type associations using network and transition probability approaches // Psychological Medicine. – 2019. – P. 1–9.
107. 107. Gold A. K., Sylvia L. G. The role of sleep in bipolar disorder // Nature and science of sleep. – 2016. – Vol. 8. – P. 207.
108. 108. Javinsky R. Sleep Architecture in Depressed Patients Treated with Desvenlafaxine. – 2017.
109. 109. Reading P., Wilson S. J. Pharmacological treatment of insomnia and parasomnias // Sleep Disorders in Neurology, S. Overeem, P. Reading, Eds. (John Wiley & Sons Ltd, 2018). – 2018. – P. 61–72.
110. 110. Wichniak A. et al. Effects of antidepressants on sleep //Current psychiatry reports. – 2017. – Vol. 19. – №9. – P. 63.
111. 111. Fujishiro H. et al. Clinical profiles of late– onset psychiatric patients exhibiting incidental REM sleep without atonia // Journal of Neural Transmission. – 2019. – Vol. 126. – №8. – P. 1095–1104.
112. 112. Adam W. et al. Effects of Antidepressants on Sleep // Current Psychiatry Reports. – 2017. – Vol. 19. – №9.
113. 113. Hein M. et al. Impact of number of sleep ultradian cycles on polysomnographic parameters related to REM sleep in major depression: Implications for future sleep research in psychiatry // Psychiatry Research. – 2020. – Vol. 285. – P. 112818.
114. 114. Hein M. et al. Alterations of neural network organisation during rapid eye movement sleep and slow– wave sleep in major depression: implications for diagnosis, classification, and treatment // Psychiatry Research: Neuroimaging. – 2019. – Vol. 291. – P. 71–78.
115. 115. Riemann D. et al. Sleep, insomnia, and depression // Neuropsychopharmacology. – 2020. – Vol. 45. – №1. – P. 74–89.
116. 116. Hoyos C.M. et al. Circadian rhythm and sleep alterations in older people with lifetime depression: a case– control study // BMC psychiatry. – 2020. – Vol. 20. – P. 1–9.
117. 117. Ozdemir P.G., Atilla E.A Supportive Therapeutic and Diagnostic Modality: Sleep Deprivation // Sleep and Hypnosis (Online). – 2017. – Vol. 19. – №3. – P. 78–79.
118. 118. McCarthy A. et al. REM sleep homeostasis in the absence of REM sleep: Effects of antidepressants // Neuropharmacology. – 2016. – Vol. 108. – P. 415–425.
119. 119. Schmitt K., Holsboer– Trachsler E., Eckert A. BDNF in sleep, insomnia, and sleep deprivation // Annals of medicine. – 2016. – Vol. 48. – №1–2. – P. 42–51.
120. 120. Rahmani M., Rahmani F., Rezaei N. The Brain – Derived Neurotrophic Factor: Missing Link Between Sleep Deprivation, Insomnia, and Depression // Neurochemical Research. – 2020. – Vol. 45. – №2. – P. 221–231.
121. 121. Zhang M.Q. et al. Neural Plasticity Is Involved in Physiological Sleep, Depressive Sleep Disturbances, and Antidepressant Treatments // Neural Plasticity. – 2017. – Vol. 2017.
122. 122. Oliveira S. et al. Impact of genetic variations in ADORA2A gene on depression and symptoms: A cross– sectional population– based study // Purinergic Signalling. – 2019. – Vol. 15. – №1. – P. 37–44.
123. 123. Gjertsen F., Bruzzone S., Griffiths C. E. Burden of suicide presented as one of the leading causes of death: uncover facts or misrepresent statistics? // Journal of global health. – 2019. – Vol. 9. – №1.
124. 124. Cunningham R.M., Walton M.A., Carter P.M. The major causes of death in children and adolescents in the United States // New England Journal of Medicine. – 2018. – Vol. 379. – №25. – P. 2468–2475.
125. 125. Østergaard M.L.D., Nordentoft M., Hjorthøj C. Associations between substance use disorders and suicide or suicide attempts in people with mental illness: a Danish nation– wide, prospective, register– based study of patients diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality disorder // Addiction. – 2017. – Vol. 112. – №7. – P. 1250–1259.
126. 126. Icick R. et al. Gender– specific study of recurrent suicide attempts in outpatients with multiple substance use disorders //Journal of affective disorders. – 2018. – Vol. 241. – P. 546–553.
127. 127. Wasserman D. Alcohol, other psychoactive substance use disorders, and suicide // Suicide: An Unnecessary Death. – 2016. – P. 73.
128. 128. Pigeon W.R., Bishop T.M., Krueger K.M. Insomnia as a precipitating factor in new onset mental illness: a systematic review of recent findings // Current psychiatry reports. – 2017. – Vol. 19. – №8. – P. 44.
129. 129. Chen P.J. et al. Relapse insomnia increases greater risk of anxiety and depression: evidence from a population– based 4– year cohort study // Sleep Medicine. – 2017. – Vol. 38. – P. 122–129.
130. 130. McDonald K.C., Saunders K.E.A., Geddes J.R. Sleep problems and suicide associated with mood instability in the Adult Psychiatric Morbidity Survey, 2007 // Australian & New Zealand Journal of Psychiatry. – 2017. – Vol. 51. – №8. – P. 822–828.
131. 131. Mars B. et al. Predictors of future suicide attempt among adolescents with suicidal thoughts or non– suicidal self– harm: a population– based birth cohort study // The Lancet Psychiatry. – 2019. – Vol. 6. – №4. – P. 327–337.
132. 132. Hein M. et al. Similar polysomnographic pattern in primary insomnia and major depression with objective insomnia: a sign of common pathophysiology? // BMC psychiatry. – 2017. – Vol. 17. – №1. – P. 273.
133. 133. Nishida M., Nakashima Y., Nishikawa T. Slow sleep spindle and procedural memory consolidation in patients with major depressive disorder // Nature and science of sleep. – 2016. – Vol. 8. – P. 63.
134. 134. Wang X., Cheng S., Xu H. Systematic review and meta– analysis of the relationship between sleep disorders and suicidal behaviour in patients with depression // BMC psychiatry. – 2019. – Vol. 19. – №1. – P. 303.
135. 135. Bishop T.M. et al. Sleep, suicide behaviors, and the protective role of sleep medicine // Sleep Medicine. – 2020. – Vol. 66. – P. 264–270.
136. 136. Sullivan-Tibbs M.A. et al. Sleep disturbances and suicide – New battles for veterans of US wars in Afghanistan and Iraq: A retrospective review // Social Work in Mental Health. – 2019. – Vol. 17. – №2. – P. 222–236.
137. 137. Ennis C.R. et al. Nightmares and nonsuicidal self– injury: the mediating role of emotional dysregulation // Comprehensive psychiatry. – 2017. – Vol. 76. – P. 104–112.
138. 138. Pfeffer M., Korf H.W., Wicht H. Synchronizing effects of melatonin on diurnal and circadian rhythms // General and comparative endocrinology. – 2018. – Т. 258. – P. 215–221.
139. 139. Reiter R.J. et al. Melatonin as an antioxidant: under promises but over delivers // Journal of pineal research. – 2016. – Vol. 61. – №3. – P. 253–278.
140. 140. Tamura H. et al. Antioxidative action of melatonin and reproduction // Glycative Stress Research. – 2019. – Vol. 6. – №3. – P. 192–197.
141. 141. Srinivasan V. et al. Melatonin, sleep, circadian rhythm, and mood disorders // Melatonin, Neuroprotective Agents and Antidepressant Therapy. – Springer, New Delhi, 2016. – P. 117–127.
142. 142. Nussbaumer– Streit B. et al. Melatonin and agomelatine for preventing seasonal affective disorder // Cochrane Database of Systematic Reviews. – 2019. – №6.
143. 143. Sundberg I. et al. Salivary melatonin in relation to depressive symptom severity in young adults // PLoS One. – 2016. – Т. 11. – №4. – P. e0152814.
144. 144. Coleman M.Y. et al. Advanced melatonin onset relative to sleep in women with unmedicated major depressive disorder // Chronobiology international. – 2019. – Vol. 36. – №10. – P. 1373–1383.
145. 145. Shirinzadeh H. et al. Bioisosteric modification on melatonin: synthesis of new naphthalene derivatives, in vitro antioxidant activity and cytotoxicity studies // Brazilian Journal of Pharmaceutical Sciences. – 2020. – Vol. 56.
146. 146. Firake B. M., Siddaiah M., Pathak P. V. Review on Agomelatine: A Novel Melatonergic Antidepressant // International Journal of Advanced Research in Pharmacy and Education. – 2019. – Vol. 1. – №1. – P. 1–8.
147. 147. Buoli M. et al. Agomelatine for the treatment of generalized anxiety disorder // Expert Opinion on Pharmacotherapy. – 2017. – Vol. 18. – №13. – P. 1373–1379.
148. 148. Konstantakopoulos G., Dimitrakopoulos S., Michalopoulou P. G. The preclinical discovery and development of agomelatine for the treatment of depression // Expert opinion on drug discovery. – 2020. – P. 1–12.
149. 149. Englisch S. et al. Agomelatine for the treatment of major depressive episodes in schizophrenia– spectrum disorders: an open– prospective proof– of– concept study // Journal of clinical psychopharmacology. – 2016. – Vol. 36. – №6. – P. 597–607.
150. 150. Potměšil P. What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice? // Therapeutic advances in psychopharmacology. – 2019. – Vol. 9. – P. 2045125319855206.
151. 151. Emet M. et al. A review of melatonin, its receptors and drugs // The Eurasian journal of medicine. – 2016. – Vol. 48. – №2. – P. 135.
152. 152. Jin Y. et al. The role of BDNF in the neuroimmune axis regulation of mood disorders // Frontiers in neurology. – 2019. – Vol. 10. – P. 515.
153. 153. Kang J.M. et al. Comparison of psychiatric symptoms in patients with obstructive sleep apnea, simple snoring, and normal controls // Psychosomatic medicine. – 2018. – Vol. 80. – №2. – P. 193–199.
154. 154. Piotrowski C. Co– Morbidity of Sleep Disorders in Veterans with PTSD: An Integrated Synopsis of 109 Studies (1995–2020) // SIS Journal of Projective Psychology & Mental Health. – 2020. – Vol. 27. – №2. – P. 83–97.
155. 155. Rosenzweig I., Weaver T. E., Morrell M. J. Obstructive Sleep Apnea and the Central Nervous System // Sleep and Breathing Disorders E– Book. – 2016. – P. 245.
156. 156. Mokhlesi B., Ham S.A., Gozal D. The effect of sex and age on the comorbidity burden of OSA: an observational analysis from a large nationwide US health claims database // European Respiratory Journal. – 2016. – Vol. 47. – №4. – P. 1162–1169.
157. 157. Chernyshev O.Y., McCarty D.E., Chesson A.L. Inflammatory Mediators in Obstructive Sleep Apnea // Neuroinflammation. – Academic Press, 2018. – P. 449–49.
158. 158. Taylor K. S. et al. Cortical autonomic network gray matter and sympathetic nerve activity in obstructive sleep apnea // Sleep. – 2018. – Vol. 41. – №2. – P. zsx208.
159. 159. Zhao F., Yang J., Cui R. Effect of hypoxic injury in mood disorder // Neural plasticity. – 2017. – Vol. 2017.
160. 160. McNicholas W.T. Obstructive sleep apnea and comorbidity– an overview of the association and impact of continuous positive airway pressure therapy // Expert review of respiratory medicine. – 2019. – Vol. 13. – №3. – P. 251–261.
161. 161. Cross N.E. et al. Structural brain correlates of obstructive sleep apnea in older adults at risk for dementia // European Respiratory Journal. – 2018. – Vol. 52. – №1.
162. 162. Navarro R.C. et al. Cerebral hemodynamics is altered in patients with sleep apnea/hypopnea syndrome // Springerplus. – 2016. – Vol. 5. – №1. – P. 51.
163. 163. Schwarz E.I. et al. Nocturnal cerebral hypoxia in obstructive sleep apnea: a randomised controlled trial // European Respiratory Journal. – 2018. – Vol. 51. – №5.
164. 164. Devita M. et al. Obstructive sleep apnea and its controversial effects on cognition // Journal of clinical and experimental neuropsychology. – 2017. – Vol. 39. – №7. – P. 659–669.
165. 165. Um Y.H., Hong S.C., Jeong J.H. Sleep problems as predictors in attention– deficit hyperactivity disorder: Causal mechanisms, consequences and treatment // Clinical Psychopharmacology and Neuroscience. – 2017.
166. 166. Devita M. Neuropsychology of sleep and breathing: the effects of obstructive sleep apnea syndrome on cognition. – 2018.
167. 167. Macey P.M. Damage to the hippocampus in obstructive sleep apnea: a link no longer missing. – 2019.
168. 168. Zhou L., Liu G., Ouyang R. Altered Hippocampus Functional Networks and the Relationship with Neurocognitive Impairment in Patients with Moderate and Severe Obstructive Sleep Apnea // A109. SRN: When brain meets brawn: the intersection of neurocognitive and epidemiological studies. – American Thoracic Society, 2020. – P. A2703– A2703.
169. 169. Macey P.M. et al. Sex– specific hippocampus volume changes in obstructive sleep apnea // Neuroimage: Clinical. – 2018. – Vol. 20. – P. 305–317.
170. 170. Shah F. et al. Upregulated expression of brain– derived neurotrophic factor in soft palate muscles of snorers and obstructive sleep apnea patients. – 2018.
171. 171. Eckert A. et al. S88. Young Male «Owls’ Present With Decreased Levels of Brain– Derived Neurotrophic Factor: Increased Risk for Depression? // Biological Psychiatry. – 2018. – Vol. 83. – №9. – P. S381.
172. 172. Flores K. R. et al. Protective role of brain derived neurotrophic factor (BDNF) in obstructive sleep apnea syndrome (OSAS) patients // Plos one. – 2020. – Vol. 15. – №1. – P. e0227834.
173. 173. Andrewes D.G., Jenkins L.M. The role of the amygdala and the ventromedial prefrontal cortex in emotional regulation: implications for post– traumatic stress disorder // Neuropsychology review. – 2019. – P. 1–24.
174. 174. Ravassard P. et al. REM sleep– dependent bidirectional regulation of hippocampal– based emotional memory and LTP // Cerebral Cortex. – 2016. – Vol. 26. – №4. – P. 1488–1500.
175. 175. Vandekerckhove M., Wang Y. Emotion, emotion regulation and sleep: an intimate relationship // Aims Neuroscience. – 2018. – Vol. 5. – №1. – P. 1.
176. 176. Padez– Vieira F., Afonso P. Sleep disturbances in anorexia nervosa // Advances in Eating Disorders. – 2016. – Vol. 4. – №2. – P. 176–188.
177. 177. Zhang Y., Gruber R. Focus: Attention Science: Can Slow– Wave Sleep Enhancement Improve Memory? A Review of Current Approaches and Cognitive Outcomes // The Yale journal of biology and medicine. – 2019. – Vol. 92. – №1. – P. 63.
178. 178. Bartsch U. et al. Neurophysiological predictors of memory impairment in schizophrenia: decoupled slow– wave dynamics during non– REM sleep // bioRxiv. – 2019. – P. 578039.
179. 179. Göder R. et al. Psychotic– like experiences in patients with insomnia or sleep apnea: Associations with sleep parameters // Sleep Medicine. – 2020.
180. 180. Liu C. J. et al. 0503 Rem Predominant Obstructive Sleep Apnea and Hypertension: A Cross– sectional Study in Clinical Sample // Sleep. – 2019. – Vol. 42. – №Supplement_1. – P. A201– A202.
181. 181. Alzoubaidi M., Mokhlesi B. Obstructive sleep apnea during REM sleep: Clinical relevance and therapeutic implications // Current opinion in pulmonary medicine. – 2016. – Vol. 22. – №6. – P. 545.
182. 182. Williams S.G., Collen J.F., Lettieri C.J. The continued search for optimal therapy in patients with OSA and PTSD // Journal of Clinical Sleep Medicine. – 2017. – Vol. 13. – №6. – P. 849–849.
183. 183. Jones A.M. The Influence of Gender, Weight, and Age on OSA Progression in REM and NREM Sleep: дис. – Emory University, 2019.
184. 184. Lee S.A., Paek J.H., Han S.H. REM– related sleep– disordered breathing is associated with depressive symptoms in men but not in women // Sleep and Breathing. – 2016. – Vol. 20. – №3. – P. 995–1002.
185. 185. O'Leary K. et al. Sleep quality in healthy and mood– disordered persons predicts daily life emotional reactivity // Cognition and Emotion. – 2017. – Vol. 31. – №3. – P. 435–443.
186. 186. D’Onofrio S., Garcia– Rill E. Bipolar disorder, depression, and arousal // Arousal in Neurological and Psychiatric Diseases. – Academic Press, 2019. – P. 55–65.
187. 187. Luo Y. et al. Evidence synthesis, practice guidelines and real– world prescriptions of new generation antidepressants in the treatment of depression: a protocol for cumulative network meta– analyses and meta– epidemiological study // BMJ open. – 2018. – Vol. 8. – №12.
188. 188. De Crescenzo F. et al. Real– world effect of antidepressants for depressive disorder in primary care: protocol of a population– based cohort study // Evidence– based mental health. – 2020. – Vol. 23. – №3. – P. 122–126.
189. 189. Haller E. et al. Antidepressant prescription practice and related factors in Switzerland: a cross– sectional analysis of health claims data // BMC psychiatry. – 2019. – Vol. 19. – №1. – P. 196.
190. 190. Voegeli G. et al. Progress in elucidating biomarkers of antidepressant pharmacological treatment response: a systematic review and meta– analysis of the last 15 years // Drugs. – 2017. – Vol. 77. – №18. – P. 1967–1986.
191. 191. Monti J.M. The effect of second– generation antipsychotic drugs on sleep parameters in patients with unipolar or bipolar disorder // Sleep Medicine. – 2016. – Vol. 23. – P. 89–96.
192. 192. Herrick L.M. et al. Effects of amitriptyline and escitalopram on sleep and mood in patients with functional dyspepsia // Clinical Gastroenterology and Hepatology. – 2018. – Vol. 16. – №3. – P. 401–406.
193. 193. Doghramji K., Jangro W. C. Adverse effects of psychotropic medications on sleep // Psychiatric Clinics. – 2016. – Vol. 39. – №3. – P. 487–502.
194. 194. Betti L., Palego L., Giannaccini G. Depression, Insomnia and Atypical Antidepressants // Frontiers in Clinical Drug Research– CNS and Neurological Disorders. – 2018. – Vol. 6. – P. 1.
195. 195. Matsuda Y. et al. Chronic antidepressant treatments rescue reduced REM sleep theta power in a rat social defeat stress model of depression // bioRxiv. – 2020.
196. 196. Pesonen A. K. et al. REM sleep fragmentation associated with depressive symptoms and genetic risk for depression in a community– based sample of adolescents // Journal of affective disorders. – 2019. – Vol. 245. – P. 757–763.
197. 197. Boafo A. et al. Sleep architecture in adolescents hospitalized during a suicidal crisis // Sleep medicine. – 2019. – Vol. 56. – P. 41–46.
198. 198. Dijkstra F. et al. Frequency and characteristic features of REM sleep without atonia // Clinical Neurophysiology. – 2019. – Vol. 130. – №10. – P. 1825–1832.
199. 199. Lee K. et al. The prevalence and characteristics of REM sleep without atonia (RSWA) in patients taking antidepressants // Journal of Clinical Sleep Medicine. – 2016. – Vol. 12. – №3. – P. 351–355.
200. 200. Liu Y. et al. Treatment of insomnia with tricyclic antidepressants: a meta– analysis of polysomnographic randomized controlled trials // Sleep Medicine. – 2017. – Vol. 34. – P. 126–133.
201. 201. Jimenez X.F. Beyond depression: Other uses for tricyclic antidepressants // Cleveland Clinic Journal of Medicine. – 2019. – Vol. 86. – №12. – P. 807.
202. 202. Aarts N. et al. Use of selective serotonin reuptake inhibitors and sleep quality: a population– based study // Journal of Clinical Sleep Medicine. – 2016. – Vol. 12. – №7. – P. 989–995.
203. 203. Tan L. et al. Duloxetine– induced rapid eye movement sleep behavior disorder: a case report // BMC psychiatry. – 2017. – Vol. 17. – №1. – P. 1–5.
204. 204. Schulte W. Kombinierte psycho– und pharmakotherapie bei melancholikern // Probleme der pharmakopsychiatrischen Kombinations– und Langzeitbehandlung. – Karger Publishers, 1966. – P. 150–169.
205. 205. Steinberg H., Hegerl U. Johann Christian August Heinroth on sleep deprivation as a therapeutic option for depressive disorders // Sleep medicine. – 2014. – Vol. 15. – №9. – P. 1159–1164.
206. 206. Pflug B., Tolle R. Therapy for endogenous depression by means of sleep deprivation // Der Nervenarzt. – 1971.
207. 207. Kragh M. et al. Wake and light therapy for moderate– to– severe depression– a randomized controlled trial // Acta Psychiatrica Scandinavica. – 2017. – Vol. 136. – №6. – P. 559–570.
208. 208. Kragh M. et al. Experiences of wake and light therapy in patients with depression: A qualitative study // International Journal of Mental Health Nursing. – 2017. – Vol. 26. – №2. – P. 170–180.
209. 209. Kirschbaum I. et al. Short– term effects of wake– and bright light therapy on sleep in depressed youth // Chronobiology international. – 2018. – Vol. 35. – №1. – P. 101–110.
210. 210. Steinberg L.J., Stewart J.W. Wake Therapy: A Novel Protocol for Rapid Treatment of Treatment Refractory Depression in Inpatients //Biological psychiatry. – 360 park ave south, New York, NY 10010–1710 USA: Elsevier science ink, 2016. – Vol. 79. – №9. – P. 206S– 206S.
211. 211. Yoshiike T. et al. Association of circadian properties of temporal processing with rapid antidepressant response to wake and light therapy in bipolar disorder // Journal of Affective Disorders. – 2020. – Vol. 263. – P. 72–79.
212. 212. Winkler D. et al. Usage of therapeutic sleep deprivation: a survey in psychiatric hospitals in Austria, Germany, and Switzerland // Behavioral sleep medicine. – 2018.
213. 213. Wu J.C., Bunney W.E. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis // The American journal of psychiatry. – 1990.
214. 214. Holst S. C., Valomon A., Landolt H. P. Sleep pharmacogenetics: personalized sleep– wake therapy // Annual review of pharmacology and toxicology. – 2016. – Vol. 56. – P. 577–603.
215. 215. Wirz– Justice A., Benedetti F. Perspectives in affective disorders: Clocks and sleep // European Journal of Neuroscience. – 2020. – Vol. 51. – №1. – P. 346–365.
216. 216. Khalifeh A. H. The effect of chronotherapy on depressive symptoms: Evidence– based practice // Saudi medical journal. – 2017. – Vol. 38. – №5. – P. 457.
217. 217. Kurczewska E. et al. Augmentation of pharmacotherapy by sleep deprivation with sleep phase advance in treatment– resistant depression // Pharmacopsychiatry. – 2019. – Vol. 52. – №04. – P. 186–192.
218. 218. Sikkens D. et al. Combined sleep deprivation and light therapy: Clinical treatment outcomes in patients with complex unipolar and bipolar depression // Journal of Affective Disorders. – 2019. – Vol. 246. – P. 727–730.
219. 219. Danilenko K. et al. Six day combined partial wake and light therapy for unipolar depression // European Neuropsychopharmacology. – 2019. – Vol. 29. – P. S411– S411.
220. 220. Kragh M. Wake and light therapy improved sleep in patients with moderate to severe depression // Sleep Medicine. – 2017. – Vol. 40.
221. 221. Trautmann N. et al. Response to therapeutic sleep deprivation: a naturalistic study of clinical and genetic factors and post– treatment depressive symptom trajectory // Neuropsychopharmacology. – 2018. – Vol. 43. – №13. – P. 2572–2577.
222. 222. Suzuki M. et al. Does early response predict subsequent remission in bipolar depression treated with repeated sleep deprivation combined with light therapy and lithium? // Journal of affective disorders. – 2018. – Vol. 229. – P. 371–376.
223. 223. Finan P. H. et al. Partial sleep deprivation attenuates the positive affective system: effects across multiple measurement modalities // Sleep. – 2017. – Vol. 40. – №1.
224. 224. Ramirez-Mahaluf J.P. et al. Effectiveness of Sleep Deprivation in Treating Acute Bipolar Depression as Augmentation Strategy: A Systematic Review and Meta– Analysis // Frontiers in Psychiatry. – 2020. – Vol. 11.
225. 225. Hu B. et al. Meta-analysis of the effects of sleep deprivation on depression in patients and animals // bioRxiv. – 2020.
226. 226. Khan M.H.R. et al. Sleep Deprivation and Cognitive Performances: Methodological Processes towards Suggestive Mechanisms // Research Journal of Pharmacy and Technology. – 2018. – Vol. 11. – №8. – P. 3658–3666.
227. 227. Oіpiсska-Lischka M. et al. The influence of 24– hr sleep deprivation on psychomotor vigilance in young women and men // Nature and science of sleep. – 2020. – Vol. 12. – P. 125.
228. 228. Kujawski S. et al. The impact of total sleep deprivation upon cognitive functioning in firefighters // Neuropsychiatric disease and treatment. – 2018. – Vol. 14. – P. 1171.
229. 229. Wang L. et al. Sleep deprivation disturbed regional brain activity in healthy subjects: evidence from a functional magnetic resonance– imaging study // Neuropsychiatric disease and treatment. – 2016. – Vol. 12. – P. 801.
230. 230. Wu J.C., Bunney B.G. Sleep deprivation therapy: A rapid-acting antidepressant // Sleep and Psychosomatic Medicine. – 2017. – P. 295.
231. 231. Pires G.N. et al. Effects of acute sleep deprivation on state anxiety levels: a systematic review and meta– analysis // Sleep medicine. – 2016. – Vol. 24. – P. 109–118.
232. 232. van Calker D. et al. The role of adenosine receptors in mood and anxiety disorders // Journal of neurochemistry. – 2019. – Vol. 151. – №1. – P. 11–27.
233. 233. Bronkhorst E., Motubatse J. Bipolar disorder: an overview // South African Family Practice. – 2017. – Т. 59. – №2. – С. 14–19.